INOVIO PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | -32.2% | -32.2% | -25.0% |
| FY2012 | -57.3% | -57.3% | -43.6% |
| FY2013 | -125.9% | -125.9% | -74.8% |
| FY2014 | -32.5% | -32.5% | -27.4% |
| FY2015 | -16.6% | -16.6% | -13.6% |
| FY2016 | -59.8% | -59.8% | -42.5% |
| FY2017 | -61.9% | -61.9% | -47.1% |
| FY2018 | -111.5% | -111.5% | -74.0% |
| FY2019 | -3,474.7% | -3,474.7% | -82.9% |
| FY2020 | -36.1% | -36.1% | -30.8% |
| FY2021 | -76.0% | -76.0% | -61.2% |
| FY2022 | -125.8% | -125.8% | -80.3% |
| FY2023 | -115.1% | -115.1% | -79.0% |
| FY2024 | -156.6% | -156.6% | -94.7% |
| FY2025 | -352.5% | -352.5% | -114.3% |